
Next-Generation IVD Market by Product (Consumables, Instruments, Software), Application (Autoimmune Diseases, Cardiology, Diabetes), End-user - Global Forecast 2024-2030
Description
Next-Generation IVD Market by Product (Consumables, Instruments, Software), Application (Autoimmune Diseases, Cardiology, Diabetes), End-user - Global Forecast 2024-2030
The Next-Generation IVD Market size was estimated at USD 80.22 billion in 2023 and expected to reach USD 83.58 billion in 2024, at a CAGR 7.16% to reach USD 130.23 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Next-Generation IVD Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Next-Generation IVD Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Next-Generation IVD Market, highlighting leading vendors and their innovative profiles. These include ABL SA Group, Agilent Technologies Inc., Archer by Integrated DNA Technologies, Inc., Becton, Dickinson and Company, Biomérieux SA, BioVendor – Laboratorní medicína A.S., Cerba Research NV, Curetis N.V., Danaher Corporation, F. Hoffmann-La Roche Ltd., Fulgent Genetics, Inc., Geneseeq Technology Inc., Genomic Labs Ltd., Illumina, Inc., Invivoscribe, Inc., NGenBio Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Pillar Biosciences Inc., QIAGEN GmbH, Sophia Genetics SA, Sysmex Europe SE, Tempus Labs, Inc., Thermo Fisher Scientific Inc., Trivitron Healthcare, and Vela Diagnostics Holding Pte Ltd..
Market Segmentation & Coverage
This research report categorizes the Next-Generation IVD Market to forecast the revenues and analyze trends in each of the following sub-markets:
Product
Consumables
Instruments
Software
Application
Autoimmune Diseases
Cardiology
Diabetes
Infectious Diseases
Nephrology
Oncology
End-user
Academic & Research Institutions
Diagnostic Laboratories
Hospitals & Clinics
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Next-Generation IVD Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Next-Generation IVD Market?
3. What are the technology trends and regulatory frameworks in the Next-Generation IVD Market?
4. What is the market share of the leading vendors in the Next-Generation IVD Market?
5. Which modes and strategic moves are suitable for entering the Next-Generation IVD Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
191 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Next-Generation IVD Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rising aging population across the globe and growing prevalence of chronic diseases
- 5.1.1.2. Increasing adoption next generation IVD tests to improve precision medicine
- 5.1.2. Restraints
- 5.1.2.1. Need of appropriate healthcare professionals to improve patient care
- 5.1.3. Opportunities
- 5.1.3.1. Advancements in technology used for next generation IVD
- 5.1.3.2. Rising adoption of Point-of-care (POC) testing in IVD industry
- 5.1.4. Challenges
- 5.1.4.1. Stringent regulations impacting the next generation IVD
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Next-Generation IVD Market, by Product
- 6.1. Introduction
- 6.2. Consumables
- 6.3. Instruments
- 6.4. Software
- 7. Next-Generation IVD Market, by Application
- 7.1. Introduction
- 7.2. Autoimmune Diseases
- 7.3. Cardiology
- 7.4. Diabetes
- 7.5. Infectious Diseases
- 7.6. Nephrology
- 7.7. Oncology
- 8. Next-Generation IVD Market, by End-user
- 8.1. Introduction
- 8.2. Academic & Research Institutions
- 8.3. Diagnostic Laboratories
- 8.4. Hospitals & Clinics
- 9. Americas Next-Generation IVD Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific Next-Generation IVD Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
- 11. Europe, Middle East & Africa Next-Generation IVD Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
- 12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. ABL SA Group
- 13.1.2. Agilent Technologies Inc.
- 13.1.3. Archer by Integrated DNA Technologies, Inc.
- 13.1.4. Becton, Dickinson and Company
- 13.1.5. Biomérieux SA
- 13.1.6. BioVendor – Laboratorní medicína A.S.
- 13.1.7. Cerba Research NV
- 13.1.8. Curetis N.V.
- 13.1.9. Danaher Corporation
- 13.1.10. F. Hoffmann-La Roche Ltd.
- 13.1.11. Fulgent Genetics, Inc.
- 13.1.12. Geneseeq Technology Inc.
- 13.1.13. Genomic Labs Ltd.
- 13.1.14. Illumina, Inc.
- 13.1.15. Invivoscribe, Inc.
- 13.1.16. NGenBio Co., Ltd.
- 13.1.17. Otsuka Pharmaceutical Co., Ltd.
- 13.1.18. Pillar Biosciences Inc.
- 13.1.19. QIAGEN GmbH
- 13.1.20. Sophia Genetics SA
- 13.1.21. Sysmex Europe SE
- 13.1.22. Tempus Labs, Inc.
- 13.1.23. Thermo Fisher Scientific Inc.
- 13.1.24. Trivitron Healthcare
- 13.1.25. Vela Diagnostics Holding Pte Ltd.
- 13.2. Key Product Portfolio
- 14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
- FIGURE 1. NEXT-GENERATION IVD MARKET RESEARCH PROCESS
- FIGURE 2. NEXT-GENERATION IVD MARKET SIZE, 2023 VS 2030
- FIGURE 3. NEXT-GENERATION IVD MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. NEXT-GENERATION IVD MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. NEXT-GENERATION IVD MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. NEXT-GENERATION IVD MARKET DYNAMICS
- FIGURE 7. NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
- FIGURE 8. NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 10. NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
- FIGURE 12. NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 14. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 16. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. ASIA-PACIFIC NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. ASIA-PACIFIC NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. NEXT-GENERATION IVD MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 22. NEXT-GENERATION IVD MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.